CNS Pharmaceuticals, Inc. (CNSP) stock
CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.44+0.29 (+6.99%)
Close on Nov 18, 2026Market cap $6.49MP/E –Yield –
CNS Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
CNS Pharmaceuticals's market cap was $5.29M on Nov 11, 2026, against $3.99M a year earlier. Over the last 5 years it ranged from $1.44M to $11.57B, with a median of $626.03M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.29M | +75.4% |
| 2025 | Dec 31, 2025 | $3.02M | -99.9% |
| 2024 | Dec 31, 2024 | $2.42B | -24.6% |
| 2023 | Dec 29, 2023 | $3.21B | +66.8% |
| 2022 | Dec 30, 2022 | $1.92B | -83.4% |
| 2021 | Dec 31, 2021 | $11.57B | -34.9% |
| 2020 | Dec 31, 2020 | $17.79B | -44.8% |
| 2019 | Dec 31, 2019 | $32.21B | – |
See a number that looks wrong?